Revenue, 2025

USD 251.5 Million

Forecast, 2035

USD 864.37 Million

CAGR, 2026-2035

13.14%

Report Coverage

United States

U.S. Exoskeleton Market Trends for 2026

The U.S. exoskeleton market size was estimated at USD 251.5 million in 2025 and is predicted to increase from USD 284.55 million in 2026 to approximately USD 864.37 million by 2035, expanding at a CAGR of 13.14% from 2026 to 2035.

The growing number of spinal cord injuries is increasing the demand for exoskeletons across the U.S. Additionally, growing AI integration, expanding rehabilitation centres, increasing innovations, and launches are also enhancing the market growth.

Key Takeaways

• U.S. exoskeleton market to crossed USD 284.55 million by 2026.
• Market projected at USD 864.37 million by 2035.
• CAGR of 13.14% expected in between 2026 to 2035.
• By mobility type, the mobile segment held a dominant position in the U.S. exoskeleton market in 2025. 
• By mobility type, the fixed/stationary segment is expected to be the fastest growing during the forecast period.
• By technology type, the powered segment accounted for the highest revenue share of the market in 2025.
• By technology type, the non-powered segment is expected to be the fastest-growing during the forecast period.
• By extremity type, the lower body segment dominated the market in 2025.
• By extremity type, the upper body segment is expected to be the fastest growing during the forecast period.
• By end-use, the healthcare segment held a majority revenue share of the market in 2025.
• By end-use, the industry segment is expected to be the fastest growing during the forecast period.

What is the U.S. Exoskeleton?

The U.S. exoskeleton market is driven by high R&D investments and early adoption across healthcare and industrial sectors. The U.S. exoskeleton refers to the wearable robotic devices or suits, utilized across the U.S. to enhance, restore, or support human movements. These devices are used for mobility recovery, muscle strengthening, physical therapy support, injury prevention, supporting physically impaired individuals, and increasing endurance.

What is the Use of AI in the U.S. Exoskeleton Market?

AI offers a wide range of applications that are increasing its use in the development of exoskeletons across the U.S., where it provides adaptive movement control and tracks the patient's progress, promoting the development of personalized therapy plans. It also offers the user movement prediction, instability detections, performance tracking, and control over the motors and actuators, reducing the unnecessary power usage, driving the development of smarter exoskeletons.

What are the Trends & Future Outlook of the U.S. Exoskeleton Market?

Growing Applications

The use of exoskeleton across the U.S. is expanding beyond the treatment of spinal cord injuries, mobility impairments, and strokes towards the industrial and military applications to reduce the workers' fatigue and injuries and to enhance the soldier endurances, respectively.

Shift Towards Home Care

A rise in the U.S. FDA approvals of the exoskeleton and a growing geriatric population are increasing the adoption of these devices for home-use rehabilitation, where the expanding telehealth platforms and insurance policies are also increasing their demand.

Technological Advancements

The growing technological advancements are driving the development of smarter, wearable, and more adaptive exoskeletons, where the focus on enhancing the user comfort and usability are also increasing the development of new control systems.

Quick Facts Table

Segmental Insights

By Mobility Insights

Why Did the Mobile Segment Dominate in the U.S. Exoskeleton Market in 2025?

The mobile segment registered its dominance over the global market in 2025, as they enhance the mobility of the users, enhancing their ability to walk and move freely. This is increasing their adoption across the rehabilitation centres in the treatment of spinal cord injuries and stroke. Additionally, they were also adopted for home care to enhance the user’s daily tasks.

Fixed/Stationary

The fixed/stationary segment is expected to gain the highest share of the market during the predicted time, due to high stability offering improved and strong support and balance, enhancing the safety and reducing the risk of falls. This is increasing their use across various hospitals and rehab centres to monitor patient movements, where their easy use is also increasing their acceptance rates.

By Technology Insights

How Powered Segment Dominated the U.S. Exoskeleton Market in 2025?

The powered segment contributed the biggest revenue share of the market in 2025, due to the presence of motors and actuators, which enhanced the ability to walk, stand, lift, and climb. Their high efficiency also increased their adoption rates for a wide range of applications across the healthcare, industrial, and military sectors.

Non-powered

The non-powered segment is expected to witness rapid growth during the predicted time, due to their lightweight designs and affordability. Furthermore, due to no use of batteries, the need for regular charging is eliminated, where its simple maintenance is also increasing their acceptance rates. This, in turn, increases their adoption rates to prevent musculoskeletal disorders and enhance workplace safety.

By Extremity Insights

Which Extremity Type Segment Held the Dominating Share of the U.S. Exoskeleton Market in 2025?

The lower body segment held the dominating share of the market in 2025, due to growth in spinal cord injuries and strokes, which affected the patient's ability to walk. This increased the demand for lower limb therapies, driving the adoption of the exoskeleton across the U.S., which supported activities like standing, climbing stairs, and walking.

Upper Body

The upper body segment is expected to show the highest growth during the upcoming years, due to growing workplace injuries. This, in turn, is increasing the use of exoskeletons across U.S. healthcare, industries, warehouses, military, and construction sectors, where the growing development of portable and lightweight designs is also increasing their demand.

By End-Use Insights

What Made Healthcare the Dominant Segment in the U.S. Exoskeleton Market in 2025?

The healthcare segment held the largest revenue share of the market in 2025, due to a rise in the focus on patient recovery and safety. The growth in spinal cord injuries and orthopedic surgeries also increased the adoption of exoskeletons across various hospitals and rehab centres of the U.S. The growth in government investments also encouraged their adoption rates.

Industry

The industry segment is expected to grow at the fastest CAGR during the upcoming years, due to growing workplace injuries. This is increasing the use of exoskeletons to perform repetitive tasks like lifting and carrying the products. Additionally, increasing technological advancements are also driving the development of new exoskeletons to enhance workplace safety, increasing their adoption rates.

Regional Insights

U.S. Drives by Strong Healthcare Sector

The U.S. exoskeleton market is expected to show significant growth during the forecast period due to the presence of a robust healthcare sector, which is increasing the adoption of the exoskeleton to deal with the growing spinal cord injuries and stroke rates. The growing R&D activities, government investments, and technological advancements are also increasing their adoption rates across various sectors, which is promoting the market growth.

U.S. Exoskeleton Market Value Chain Analysis

R&D

• The R&D of the U.S. exoskeleton focuses on the long-life battery integration, AI-driven intent recognition, soft robotic textile, and the development of more intuitive and lightweight wearable systems.
• Key players: Ekso Bionics Holdings, Inc., Sarcos Technology & Robotics Corp., HeroWear, LLC.

Clinical Trials and Regulatory Approvals

• The safety, skin integrity, joint alignment, risk of falls, functional independence, and diagnostic efficacy through the 10-meter walk test are evaluated in the clinical trials and regulatory approvals of the U.S. exoskeleton.
• Key players: Ekso Bionics Holdings, Inc., Myomo, Inc., Lifeward Ltd.

Packaging and Serialization

• The packaging and serialization of the U.S. exoskeleton involves the use of custom-molded protective cases for medical units and heavy-duty crating for industrial systems, along with the unique device identification (UDI) and GS1-standards serialization.
• Key players: Ekso Bionics Holdings, Inc., Lifeward Ltd.

Distribution to Hospitals, Pharmacies

• The specialized medical equipment distributors and direct sales forces are responsible for the distribution of the exoskeletons across the U.S. hospitals and pharmacies.
• Key players: Ekso Bionics Holdings, Inc., Lifeward Ltd.

Patient Support and Services

• The gait training programs, 24/7 technical support, and insurance reimbursement assistance are provided in the patient support and services of the U.S. exoskeletons.
• Key players: Ekso Bionics Holdings, Inc., Myomo, Inc., Lifeward Ltd.

Who are the U.S. Exoskeleton Market Top Vendors and What are Their Offerings?

SWOT Analysis

Strengths

• The U.S. exoskeleton offers support to the muscles and joints, which increases their use in the rehabilitation centres.
• They also help in enhancing mobility, driving their use for patients with weak muscles and paralysis.
• They also enhanced muscle strength, natural movement, and blood circulation, increasing their use in stroke and spinal cord injuries.
• They are also being used by the physiotherapist to offer support to the patient and improve their movements.

Weaknesses

• High cost associated with the devices acts as the major weakness in the U.S. exoskeleton market, limiting their accessibility and use.
• Their bulky designs also make the patient uncomfortable and difficult to wear, reducing their use.

Opportunities

• The increasing incidence of spinal cord injuries are increasing the adoption of the exoskeleton across the U.S.
• The growth in the geriatric population is also increasing their demand for mobility support.
• Expanding rehabilitation centres and home-based care are also increasing their adoption rates.
• Technological advances are driving their innovations as well.

Threats

• The requirement of the advanced materials, sensors, and robotics increases the manufacturing cost, limiting their innovations.
• Rapid technological changes, stringent regulations, and intense competition also reduce their innovations.

Recent Developments in the U.S. Exoskeleton Market

• In February 2026, a definitive agreement with an aim to acquire certain technology assets was announced between Lifeward Ltd. and Skelable Ltd., where the key engineering team of Skelable Ltd. will offer industrial, electrical, mechanical, and software design expertise supporting the launch of Lifeward's new upper body exoskeleton.
• In February 2026, to enhance the access and evaluation of the ReWalk Personal Exoskeleton for people with spinal cord injury (SCI), a collaboration between Lifeward and Shirley Ryan AbilityLab was announced, where they will combine clinical evaluation, patient support, and training with ReWalk.

Segments Covered in the Report

By Mobility

• Mobile
• Fixed/Stationary

By Technology

• Powered
• Non-powered

By Extremity

• Upper Body
• Lower Body
• Full Body

By End-use

• Healthcare
• Military
• Industry